Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
https://www.nature.com/articles/s41409-022-01660-3.pdf
Reference9 articles.
1. Tiwari NR, Phatak S, Sharma VR, Agarwal SK. COVID-19 and thrombotic microangiopathies. Thromb Res. 2021;202:191–8. https://doi.org/10.1016/j.thromres.2021.04.012.
2. Calabretta E, Moraleda JM, Iacobelli M, Jara R, Vlodavsky I, O’Gorman P, et al. COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. Br J Haematol. 2021;193:43–51. https://doi.org/10.1111/bjh.17240.
3. Christopeit M, Reichard M, Niederwieser C, Massoud R, Klyuchnikov E, Haase N, et al. Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection. Bone Marrow Transplant. 2021;56:1478–81. https://doi.org/10.1038/s41409-021-01225-w.
4. Dandoy CE, Rotz S, Alonso PB, Klunk A, Desmond C, Huber J, et al. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood Adv. 2021;5:1–11. https://doi.org/10.1182/bloodadvances.2020003455.
5. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116–22. https://doi.org/10.1002/hep.1840040121.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Impact of Prior COVID-19 on Noninfectious Endothelial Complications Following Allogeneic Hematopoietic Stem Cell Transplantation;Clinical Infectious Diseases;2024-06-05
2. Reply to Oltolini et al;Clinical Infectious Diseases;2024-06-04
3. Hematopoietic cell transplantation can be safely performed after COVID-19;Bone Marrow Transplantation;2023-09-19
4. Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia;Frontiers in Immunology;2023-05-23
5. Narsoplimab for severe transplant-associated thrombotic microangiopathy;Thrombosis Journal;2023-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3